1 study found for:    11312349 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Approved for marketing An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Condition: Chronic Hepatitis B
Intervention: Drug: Adefovir Dipivoxil

Indicates status has not been verified in more than two years